Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.

Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B, CREATE study group

Open source

DOI: 10.1016/j.jhepr.2023.100790
Published: 2023 Aug
Container: JHEP reports : innovation in hepatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2023.100790,
  title = {Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.},
  author = {Sonneveld MJ and Chiu SM and Park JY and Brakenhoff SM and Kaewdech A and Seto WK and Tanaka Y and Carey I and Papatheodoridi M and Colombatto P and van Bömmel F and Berg T and Zoulim F and Ahn SH and Dalekos GN and Erler NS and Brunetto M and Wedemeyer H and Cornberg M and Yuen MF and Agarwal K and Boonstra A and Buti M and Piratvisuth T and Papatheodoridis G and Chen CH and Maasoumy B and CREATE study group},
  year = {2023},
  journal = {JHEP reports : innovation in hepatology},
  doi = {10.1016/j.jhepr.2023.100790},
  url = {https://doi.org/10.1016/j.jhepr.2023.100790}
}

RIS

TY  - JOUR
TI  - Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.
AU  - Sonneveld MJ
AU  - Chiu SM
AU  - Park JY
AU  - Brakenhoff SM
AU  - Kaewdech A
AU  - Seto WK
AU  - Tanaka Y
AU  - Carey I
AU  - Papatheodoridi M
AU  - Colombatto P
AU  - van Bömmel F
AU  - Berg T
AU  - Zoulim F
AU  - Ahn SH
AU  - Dalekos GN
AU  - Erler NS
AU  - Brunetto M
AU  - Wedemeyer H
AU  - Cornberg M
AU  - Yuen MF
AU  - Agarwal K
AU  - Boonstra A
AU  - Buti M
AU  - Piratvisuth T
AU  - Papatheodoridis G
AU  - Chen CH
AU  - Maasoumy B
AU  - CREATE study group
PY  - 2023
JO  - JHEP reports : innovation in hepatology
DO  - 10.1016/j.jhepr.2023.100790
UR  - https://doi.org/10.1016/j.jhepr.2023.100790
ER  -

APA

MJ, S., SM, C., JY, P., SM, B., A, K., WK, S., Y, T., I, C., M, P., P, C., F, V. B., T, B., F, Z., SH, A., GN, D., NS, E., M, B., H, W., M, C., MF, Y., K, A., A, B., M, B., T, P., G, P., CH, C., B, M., & group, C. S. (2023). Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2023.100790

Source records

pubmed · retrieved 2026-09-26T13:31:11.892Z